For its fourth fiscal quarter (ending March 31), Steris Plc (NYSE: STE) has reported a -18% decline in E.P.S. from $1.89 a year ago to $1.55 in the current quarter. This performance was $-0.83 short […]
For its first fiscal quarter (ending March 31), SeaWorld Entertainment Inc (NYSE: SEAS) has reported E.P.S. of $-0.17 compared to $-0.26 a year ago. This performance was $0.03 better than the consensus estimate of $-0.20. […]
RadNet Inc (NASDAQ: RDNT) has reported a loss for its first fiscal quarter (ending March 31) of $-0.04 versus a loss $-0.36 for the same period a year ago. This result fell short of the […]
QuinStreet Inc (NASDAQ: QNST) has reported a loss for its third fiscal quarter (ending March 31) of $-0.13 versus a loss $-0.01 for the same period a year ago. This result fell short of the […]
Perion Network Ltd (NASDAQ: PERI) has reported E.P.S. of $0.24 for its first fiscal quarter (ending March 31) versus $0.51 for the same period a year ago — a decline of -53%. This performance was […]
Nature’s Sunshine Products Inc (NASDAQ: NATR) stock closed at $15.76 on 5/8/24 after a major decline of -17.6%. Moreover, trading volume in this decline was exceptionally high at 288% of normal. Relative to the market […]
National Research Corp (NASDAQ: NRC) stock suffered a major decline of -16.5% on 5/8/24. The shares closed at $29.76. Moreover, exceptionally high trading volume at 240% of normal accompanied the decline. The stock has declined […]
Myriad Genetics Inc (NASDAQ: MYGN) stock enjoyed a major increase of 21.1% on 5/8/24. The shares closed at $23.95. Moreover, exceptionally high trading volume at 376% of normal accompanied the advance. The stock has been […]
LCI Industries (NYSE: LCII) has reported earnings for its first fiscal quarter (ending March 31) of $1.44 versus $0.29 for the same period a year ago — an increase of 397%. This result exceeded the […]
Inogen Inc (NASDAQ: INGN) stock closed at $8.24 on 5/8/24 after a major increase of 12.9%. Moreover, trading volume in this advance was exceptionally high at 258% of normal. The stock has risen 21.2% during […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research